FDA Inspection 1248124 — EVOLUS INC
The FDA completed an inspection of EVOLUS INC on Jun 26, 2024 in Newport Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newport Beach, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)